Clinical Trial Update: Effect of Cabazitaxel on the QTc Interval in Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the effect of cabazitaxel on the QTc interval in patients with malignant neoplasms; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasms

Drugs mentioned

• Jevtana (cabazitaxel)

Snippet

Sponsor: Sanofi | Conditions: Neoplasms, Malignant | Phase 1 | Status: COMPLETED